HAYWARD, Calif.–(BUSINESS WIRE)–May 9, 2024–. Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on …
HAYWARD, Calif.–(BUSINESS WIRE)–May 9, 2024–. Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on …
In